CIK 0001861107 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Ceribell, Inc.
Sign in to watch- Ticker
- CBLL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471785452
- Phone
- (800) 436-0826
- Business address
- 360 N. PASTORIA AVENUE, SUNNYVALE, CA, 94085
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,415,987
- in 16 filings, $3.9M under 10b5-1 plans
Net −$4,415,987. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Chao Xingjuan −$2.5M President and CEO sold 12% of stake
- Blumberg Scott −$938K Chief Financial Officer sold 20% of stake
- Woo Raymond −$417K Chief Technology Officer sold 8% of stake
- Taylor Joseph Michael −$278K Director sold 21% of stake
- Foehr David −$269K Senior VP, Finance and PAO sold 25% of stake
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-02 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,472 | 11,330 | ||
| 2026-03-02 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,025 | 38,746 | ||
| 2026-03-02 | Woo Raymond Chief Technology Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,615 | 32,293 | ||
| 2026-02-24 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −781 | $19.98 | $16K | 17,550 |
| 2026-02-23 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −569 | $19.79 | $11K | 18,331 |
| 2026-02-23 | Manni Joseph S. Chief Revenue Officer | Sale | −768 | $19.79 | $15K | 26,933 |
| 2026-02-23 | Woo Raymond Chief Technology Officer | Sale | −705 | $19.79 | $14K | 166,912 |
| 2026-02-23 | Blumberg Scott Chief Financial Officer | Sale | −808 | $19.79 | $16K | 118,334 |
| 2026-02-23 | Chao Xingjuan President and CEO | Sale | −2,084 | $19.79 | $41K | 725,164 |
| 2026-02-19 | Parvizi Josef Director | Sale 10b5-1 | −16,714 | $20.27 | $339K | 722,652 |
| 2026-02-18 | Parvizi Josef Director | Sale 10b5-1 | −6,986 | $20.00 | $140K | 739,366 |
| 2026-02-17 | Parvizi Josef Director | Sale 10b5-1 | −1,300 | $20.00 | $26K | 746,352 |
| 2026-02-04 | Chao Xingjuan President and CEO | Sale 10b5-1 | −14,000 | $20.16 | $282K | 727,248 |
| 2026-02-04 | Chao Xingjuan President and CEO | Option exercise 10b5-1 | +1,446 | $4.70 | $7K | 728,694 |
| 2026-02-04 | Chao Xingjuan President and CEO | Sale 10b5-1 | −1,446 | $20.16 | $29K | 727,248 |
| 2026-02-04 | Chao Xingjuan President and CEO | Option exercise 10b5-1 | +23,554 | $4.70 | $111K | 750,802 |
| 2026-02-04 | Chao Xingjuan President and CEO | Sale 10b5-1 | −23,554 | $20.16 | $475K | 727,248 |
| 2026-02-04 | Chao Xingjuan President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,446 | 295,940 | ||
| 2026-02-04 | Chao Xingjuan President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −23,554 | 195,693 | ||
| 2026-02-03 | Foehr David Senior VP, Finance and PAO | Option exercise 10b5-1 | +3,403 | $4.70 | $16K | 22,303 |
Page 9 of 17 · 330 trades